2 de marzo de 2022 • 1 minute read
Incentivizing diverse representation in clinical trials
Diverse representation in clinical trials is critical in achieving greater equity and better healthcare outcomes. In this episode, DLA Piper's Kirsten Axelsen and Sarah Schick are joined by Shazia Ahmad, Senior Director and Head of Patient and Physician Services at UBC, to discuss the importance of regulatory incentives to drive racial and ethnic diversity in clinical trials.
